Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
9.15
+0.16 (1.78%)
At close: Oct 28, 2026, 4:00 PM EDT
9.02
-0.13 (-1.42%)
After-hours: Oct 28, 2026, 7:30 PM EDT
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year. That makes Contineum Therapeutics the 34,808th largest employer in the world and 4,651st in the United States.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,128,588
Market Cap
344.23M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| Enanta Pharmaceuticals | 120 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
| Scribe Therapeutics | 82 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
CTNM News
- 13 days ago - Contineum price target raised to $30 from $24 at Jones - TheFly
- 14 days ago - Contineum downgraded to Neutral from Outperform at Baird - TheFly
- 15 days ago - Contineum downgraded to Neutral from Outperform at Baird - TheFly
- 4 weeks ago - Jones sees greater room for Contineum’s PIPE-791 to differentiate - TheFly
- 4 weeks ago - Contineum Therapeutics Inc trading resumes - TheFly
- 4 weeks ago - Contineum Therapeutics Inc trading halted, volatility trading pause - TheFly
- 4 weeks ago - Contineum price target lowered to $17 from $18 at Morgan Stanley - TheFly
- 4 weeks ago - Contineum resumed at Early-Stage Biotech at Goldman Sachs - TheFly